US 11,667,602 B2
Compounds and their use
Kenneth Lars Granberg, Gothenburg (SE); Shigeki Sakamaki, Osaka (JP); Ryuichi Fuchigami, Osaka (JP); Yasuki Niwa, Osaka (JP); Masakazu Fujio, Osaka (JP); Hans Fredrik Bergström, Göthenburg (SE); and Stig Jonas Boström, Göthenburg (SE)
Assigned to AstraZeneca AB, (SE); and MITSUBISHI TANABE PHARMA CORPORATION, Osaka (JP)
Filed by AstraZeneca AB, Södertälje (SE); and MITSUBISHI TANABE PHARMA CORPORATION, Osaka (JP)
Filed on Dec. 7, 2021, as Appl. No. 17/457,953.
Claims priority of provisional application 63/122,690, filed on Dec. 8, 2020.
Prior Publication US 2023/0078576 A1, Mar. 16, 2023
Int. Cl. C07C 233/81 (2006.01)
CPC C07C 233/81 (2013.01) [C07B 2200/13 (2013.01)] 6 Claims
 
1. A compound which is

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.